Stichting Biomedical Primate Research Center

Stichting Biomedical Primate Research Center is a research organisation in Rijswijk Zh, Netherlands that has taken part in 27 EU-funded projects since 2009, receiving €23.5M in EU funding and leading 1 as coordinator.

EU funding received€23.5M
EU projects27
As coordinator1
Running now5
First EU project2009
Latest project2026
CountryNetherlands
EU registration (PIC)998530320
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Stichting Biomedical Primate Research Center's own share of each project, not the project's full budget.

  • Horizon Europe€9.9M · 6 projects
  • FP7 (2007 to 2013)€7.7M · 14 projects
  • Horizon 2020€5.9M · 7 projects

Projects

27 EU-funded projects, newest first. Stichting Biomedical Primate Research Center led 1 of them as coordinator. Each links to the official record.

  • ISIDORe IIPartner

    INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €10ktheir share
  • Host4HypnozoitesPartner

    Parasite-host interactions regulating dormancy and reactivation of malaria parasites

    Horizon Europe · 2024–2030 · Project on CORDIS ↗

    €5.8Mtheir share
  • CAPTIVATEPartner

    CorrelAtes of Protective immuniTy-driven Investigation of malaria VAccine combinaTion stratEgies

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.3Mtheir share
  • TDVisionPartner

    Detailed Cortical Mechanisms of Top-Down Visual Processing

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €600ktheir share
  • TBVAC-HORIZONPartner

    Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €900ktheir share
  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €1.3Mtheir share
  • TRANSVAC-DSPartner

    DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €52ktheir share
  • TRANSVAC2Partner

    European Vaccine Research and Development Infrastructure

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €2.6Mtheir share
  • HONOURsPartner

    Host switching pathogens, infectious outbreaks and zoonosis; a Marie Sklodowska-Curie Training Network

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €255ktheir share
  • RABYD-VAXPartner

    Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €818ktheir share
  • VAC2VACPartner

    Vaccine lot to Vaccine lot comparison by consistency testing.

    Horizon 2020 · 2016–2022 · Project on CORDIS ↗

    €305ktheir share
  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

    €1.0Mtheir share
  • FLUCOPPartner

    Standardization and Development of Assays for Assessment of Influenza Vaccines Correlates of Protection

    FP7 (2007 to 2013) · 2015–2020 · Project on CORDIS ↗

    €130ktheir share
  • TBVAC2020Partner

    TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €918ktheir share
  • PRIMOMEDPartner

    Use of PRIMate MOdels to support translational MEDicine and advance disease modifying therapies for unmet medical needs

    FP7 (2007 to 2013) · 2014–2015 · Project on CORDIS ↗

    €6ktheir share
  • EDUFLUVACPartner

    Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €984ktheir share
  • SYSMALVACPartner

    Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria

    FP7 (2007 to 2013) · 2013–2014 · Project on CORDIS ↗

    €277ktheir share
  • TRIADPartner

    Tolerance Restoration In Autoimmune Diseases by selective manipulation of the CD28 costimulatory pathway

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €445ktheir share
  • WINGSPartner

    West Nile Integrated Shield Project: Epidemiology, Diagnosis and Prevention of West Nile Virus in Europe

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €508ktheir share
  • EUPRIM-NET IIPartner

    European Primate Network: Advancing 3Rs and International Standards in Biological and Biomedical Research

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €2.7Mtheir share
  • NEWTBVACPartner

    Discovery and preclinical development of new generation tuberculosis vaccines

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €778ktheir share
  • PHARVATCoordinator

    Platform for the Harmonization of Vaccine Adjuvant Testing

    FP7 (2007 to 2013) · 2009–2011 · Project on CORDIS ↗

    €90ktheir share
  • TRANSVACPartner

    European Network of Vaccine Development and Research

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €1.4Mtheir share
  • EVIMALARPartner

    Towards the establishment of a permanent European Virtual Institute dedicated to Malaria Research (EVIMalaR).

    FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗

    €93ktheir share
  • OPTIMALVACPartner

    Initiative on Optimizing Malaria Vaccine Lab Assays Evaluation

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €55ktheir share
  • MALSIGPartner

    Signalling in life cycle stages of malaria parasites

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €166ktheir share
  • INYVAXPartner

    Optimisation of the development of Poverty-Related-Diseases (PRD) vaccines by a transversal approach, addressing common gaps and challenges

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €90ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA viruses
  • arteriosclerosis
  • asthma
  • autoimmune diseases
  • catalysis
  • cell biology
  • coronaviruses
  • databases
  • drug discovery
  • emission spectroscopy
  • entomology
  • epidemiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime